Related Experiment Video

Updated: Oct 2, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.3K

IACTS position statement on "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization": section 7.1-a

Om Prakash Yadava1, Pradeep Narayan2, Chandrasekar Padmanabhan3

  • 1National Heart Institute, New Delhi, India.

Indian Journal of Thoracic and Cardiovascular Surgery
|February 28, 2022
PubMed

Insights

New clinical practice guidelines for myocardial revascularization were released by the ACC, AHA, and SCAI. The Indian Association of Cardiovascular and Thoracic Surgeons offers its perspective on the guidelines, particularly concerning coronary artery bypass surgery.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery

Background:

  • The American College of Cardiology (ACC), American Heart Association (AHA), and Society for Cardiovascular Angiography and Interventions (SCAI) have issued new clinical practice guidelines for myocardial revascularization.
  • These guidelines consolidate previous recommendations into a single comprehensive document.

Purpose of the Study:

  • To present the official viewpoint of the Indian Association of Cardiovascular and Thoracic Surgeons (IACTS) regarding the recent clinical practice guidelines for myocardial revascularization.
  • To address concerns within the surgical community regarding the updated recommendations for stable multivessel coronary artery disease.

Main Methods:

  • Review and analysis of the recently released ACC/AHA/SCAI Clinical Practice Guidelines for myocardial revascularization.
  • Formulation of the IACTS's official stance on the guideline's implications for coronary artery bypass surgery versus percutaneous coronary interventions.

Main Results:

  • The new guidelines consolidate six previous documents into one comprehensive clinical practice guideline.
  • A significant point of contention is the perceived downgrading of coronary artery bypass surgery for stable multivessel coronary artery disease, placing it alongside percutaneous coronary interventions.

Conclusions:

  • The IACTS acknowledges the consolidation of guidelines but expresses significant concern over the implications for coronary artery bypass surgery.
  • The document aims to provide a balanced perspective from the surgical fraternity on the management of multivessel coronary artery disease.

Keywords:
2021 ACC/AHA guideline on coronary artery revascularisationCABGClinical practice guidelinesMyocardial revascularisationSTS/AATS/LACES/EACTS/ESC/IACTSStable ischemic heart disease

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.4K
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.1K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
53
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
44
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
142
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
57
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
103
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
67